...
首页> 外文期刊>International Hatchery Practice >Understanding in ovo vaccination
【24h】

Understanding in ovo vaccination

机译:了解卵内疫苗接种

获取原文
获取原文并翻译 | 示例

摘要

The initial in ovo (in the egg) vaccination research was conducted by United States Department of Agriculture scientists in the early 1980s. In ovo administration of Marek's disease vaccines HVT, SB-1, CVI988 to the late stage chicken embryo has beenshown to be safe and to induce earlier immunity than post-hatch administration. The practice of in ovo vaccination was moved from the laboratory to commercial hatcheries in 1992. Commercial in ovo vaccination began in the United States and today is routine in Southeast Asia, Japan, Australia, Europe, and the Americas.
机译:最初的卵内(卵内)疫苗接种研究是由美国农业部的科学家在1980年代初期进行的。在马立克氏病疫苗的卵内给予晚期鸡胚的HVT,SB-1,CVI988安全性高,并且比孵化后给予更早的免疫。卵内疫苗接种的做法于1992年从实验室转移到商业孵化场。卵内疫苗商业接种始于美国,如今在东南亚,日本,澳大利亚,欧洲和美洲已成为常规。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号